Dr Adlinda graduated from Southampton University, UK and completed general medical training before being awarded the MRCP by the Royal College of Physician, UK. She obtained FRCR by the Royal College of Radiologist (Clinical Oncology) UK and awarded a certificate of completion (CCT) in Clinical Oncology by General Medical Council UK in 2011. She joined the University of Malaya as a Senior Lecturer and Clinical Oncologist in 2012. She is a principal and sub-investigator for several ongoing and completed clinical trials. She gives talks and presentation locally and in international meetings. Her main areas of interest include Lung, Breast, Genitourinary and Stereotactic Radiosurgery/Radiotherapy.
Tewﬁk J. Bichay, Ph.D.
Dr. Bichay obtained his B.Sc. degree in Physiology from McGill University, Montreal, his M.Sc. in Biology from Concordia University, Montreal, and his Ph.D. in Medical Biophysics from the University of Western Ontario, London, Canada. He is currently Director of Medical Physics, Radiation Oncology, the Lacks Cancer Center at Mercy Health, St. Mary’s, Grand Rapids, MI. He started his career as a radiation biologist before transitioning into medical physicist with a residency at the Ottawa Regional Cancer Center. He is an accreditation surveyor for the ACR, served for a number of years as an ABR MOC examination committee member, and is the previous President of the Great Lakes Chapter of the AAPM, and holds a patent on a compact doorless radiation vault design. He is certiﬁed in Radiation Oncology Physics by the ABMP and his present research interests include SRS and SBRT.
Anna Wrona, MD PhD,
Department of Oncology and Radiotherapy, Medical University of Gdansk
Consultant of radiation oncology and academic in one of the most exhilarating Polish cancer centers – in the Department of Oncology and Radiotherapy of Medical University of Gdańsk.
- European Thoracic Oncology Platform(ETOP)
- European Organization for Research and Treatment of Cancer(EORTC).
- Polish Society of Oncology (PTO),
- European Society for Radiotherapy and Oncology(ESTRO)
- International Association for the Study of Lung Cancer (IASLC).
- Associate editor of Journal Club column in Nowotwory Journal.
Area of interest:
- Thoracic oncology.
- Cancer molecular biology and resistance mechanisms.
- ESMO 2017.
- Polish Congress of Medical Oncology
- Conference of Polish Lung Cancer Group
- World Conference on Lung Cancer.
Current Positions and Titles
Chairman of Kasr Al-Ainy School Of Oncology (KASO), official Cancer education organization, Department of Oncology, Faculty of Medicine, Cairo University. Professor of Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt President of Africa Middle East Cancer Research Inter group. Referee for the Annals of Oncology Journal, THE BREAST, The Breast Journal (TBJ), BMC Cancer, Chemotherapy journal , Advances in Cancer Research & Treatment , Journal of the Egyptian National Cancer Institute, and the Chinese Clinical Oncology Journal. Pioneering Activity
Past chairman of the Oncology Department, Faculty of Medicine, Cairo University. First to represent the Middle East countries on the ASCO international committee, for a period of 5 years ( May 1997-May 2002) Chief editor of 2 educational books ASCO PANARAB Lymphoma Conference (1999) and the MD Anderson Cancer Centre / Cairo University joint meeting (2006) More than 80 scientific and research publications. Scientist of the Year from the International Biographical Centre, Cambridge, UK (2002) The Order of Merit,Cambridge University (2002) The Best Arab Oncologist from the Lebanese Society of Medical Oncology (LSMO,2004) The recognition award for significant contribution to the Oncology field in the middle east from UAE (Dubai -2013) Dr Azim signed the Charter of Paris against Cancer on behalf of the Arab World in February 2000.
Dr. Bouthaina Dabaja received her Medical Doctorate at the Lebanese University. She completed her clinical residencies at the American University of Beirut and The University of Texas MD Anderson Cancer Center. She began her career at MD Anderson following her residency in 2006 and has progressed from Assistant Professor to Professor and Section Chief of the Hematology Section in Radiation Oncology. Her primary clinical goal is patient care with an emphasis on maintaining and improving cure rate in patients with lymphoma while decreasing the short and long term side effects of treatment. She is extensively involved in clinical trials to investigate multiple strategies to deliver better treatment options for lymphoma patients with the goal of minimizing long term side effects on patients treated for mediastinal lymphomas which remains a great clinical challenge.
Associate Professor, Department of Radiation Oncology,
ESMO Board MemberDirk Arnold is Director of the Dept. Medical Oncology at Klinik für Tumorbiologie, Freiburg, Germany. Before taking this position, he was 2010 appointed as Director of the University Cancer Centre in Hamburg (UCCH) and held positions at the University Departments for Oncology and Haematology in Halle-Wittenberg and Berlin. His major field of scientific interest are gastrointestinal cancers, and here specifically modern therapeutic approaches in biomarker-driven decision processes, and multimodal treatment strategies, also including other specialities. Here, he serves as chairman of Colorectal Cancer Study Group of the German AIO, a major collaborative group in clinical oncology. Within the AIO framework, he served as founding member of the Central Clinical Trials Office, underlining his expertise also in methodology of clinical research. Furthermore, his interest is the organisation of larger collaborative research structures and of integrated cancer centre networks. Prof. Arnold is also member of the American Society of Clinical Oncology and Task Force Member of the National Cancer Institute, as well as Board member of the EORTC GI study group. Furthermore, he is board member of the German Society of Haematology and Medical Oncology (DGHO), and member of the German Cancer Society. Within ESMO, since 2012 he is section editor for GI cancers in the Guidelines Committee and Associate Editor with .
Consultant of Clinical Radiotherapy and Assistant Professor